Literature DB >> 26539296

Mechanisms of osteolytic and osteoblastic skeletal lesions.

G David Roodman1, Rebecca Silbermann2.   

Abstract

The bone is a frequent site for tumor metastasis, and cancer in the bone results in marked disturbances of bone remodeling that can be lytic, blastic or a combination of the two. Patients with advanced malignancies that have metastasized to the bone frequently suffer from debilitating skeletal-related events, including pathologic fractures, spinal cord compression syndromes, disorders of calcium and phosphate homeostasis and severe cancer-related pain. This review will discuss recent studies on the mechanisms responsible for osteolytic and osteoblastic metastasis and how their identification has resulted in the development of new agents for patients with metastatic bone disease.

Entities:  

Year:  2015        PMID: 26539296      PMCID: PMC4625391          DOI: 10.1038/bonekey.2015.122

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  53 in total

1.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

4.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Authors:  Yibin Kang; Wei He; Shaun Tulley; Gaorav P Gupta; Inna Serganova; Chang-Rung Chen; Katia Manova-Todorova; Ronald Blasberg; William L Gerald; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

6.  The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.

Authors:  Hai Wang; Cuijuan Yu; Xia Gao; Thomas Welte; Aaron M Muscarella; Lin Tian; Hong Zhao; Zhen Zhao; Shiyu Du; Jianning Tao; Brendan Lee; Thomas F Westbrook; Stephen T C Wong; Xin Jin; Jeffrey M Rosen; C Kent Osborne; Xiang H-F Zhang
Journal:  Cancer Cell       Date:  2015-01-15       Impact factor: 31.743

7.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 8.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

Review 9.  Pathogenesis of osteoblastic bone metastases from prostate cancer.

Authors:  Toni Ibrahim; Emanuela Flamini; Laura Mercatali; Emanuele Sacanna; Patrizia Serra; Dino Amadori
Journal:  Cancer       Date:  2010-03-15       Impact factor: 6.860

Review 10.  Role of osteocytes in multiple myeloma bone disease.

Authors:  Jesus Delgado-Calle; Teresita Bellido; G David Roodman
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

View more
  16 in total

1.  Tumor dormancy in bone.

Authors:  Vera Mayhew; Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-29

2.  Tissue-Engineered Model of Human Osteolytic Bone Tumor.

Authors:  Aranzazu Villasante; Alessandro Marturano-Kruik; Samuel T Robinson; Zen Liu; X Edward Guo; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part C Methods       Date:  2017-02       Impact factor: 3.056

Review 3.  Evaluation and management of skeletal disease in cancer care.

Authors:  Anuhya Kommalapati; Sri Harsha Tella; Mary Angelynne Esquivel; Ricardo Correa
Journal:  Crit Rev Oncol Hematol       Date:  2017-09-08       Impact factor: 6.312

Review 4.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

5.  Multimodal imaging provides insight into targeted therapy response in metastatic prostate cancer to the bone.

Authors:  Benjamin A Hoff; Jean-Christophe Brisset; Stefanie Galbán; Marcian Van Dort; David C Smith; Zachery R Reichert; Jon A Jacobson; Gary D Luker; Thomas L Chenevert; Brian D Ross
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

6.  3D models of the bone marrow in health and disease: yesterday, today and tomorrow.

Authors:  Annamarija Raic; Toufik Naolou; Anna Mohra; Chandralekha Chatterjee; Cornelia Lee-Thedieck
Journal:  MRS Commun       Date:  2018-09-25       Impact factor: 2.566

7.  HYPERCALCEMIA OF MALIGNANCY IN A CASE OF PERIPHERAL NERVE SHEATH TUMOR: ELUCIDATING THE ROLES OF SIMULTANEOUS MECHANISMS.

Authors:  Malini Ganesh; Sanford Baim
Journal:  AACE Clin Case Rep       Date:  2020-05-08

8.  Conventional finite element models estimate the strength of metastatic human vertebrae despite alterations of the bone's tissue and structure.

Authors:  Marc A Stadelmann; Denis E Schenk; Ghislain Maquer; Christopher Lenherr; Florian M Buck; Dieter D Bosshardt; Sven Hoppe; Nicolas Theumann; Ron N Alkalay; Philippe K Zysset
Journal:  Bone       Date:  2020-08-20       Impact factor: 4.626

Review 9.  Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials.

Authors:  Andrew S Gdowski; Amalendu Ranjan; Jamboor K Vishwanatha
Journal:  J Exp Clin Cancer Res       Date:  2017-08-11

Review 10.  A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?

Authors:  Francesca Salamanna; Deyanira Contartese; Melania Maglio; Milena Fini
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.